{"id":"https://openalex.org/W4361959092","doi":"https://doi.org/10.1158/1078-0432.c.6532905","title":"Data from Activation of Adaptive and Innate Immune Cells via Localized IL2 Cytokine Factories Eradicates Mesothelioma Tumors","display_name":"Data from Activation of Adaptive and Innate Immune Cells via Localized IL2 Cytokine Factories Eradicates Mesothelioma Tumors","alternate_titles":[],"publication_year":2023,"publication_date":"2023-04-01","ids":{"openalex":"https://openalex.org/W4361959092","doi":"https://doi.org/10.1158/1078-0432.c.6532905"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6532905","doi":"https://doi.org/10.1158/1078-0432.c.6532905","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6532905","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"parent_works":[],"lineage":["https://openalex.org/W4361959092"],"child_works_count":0,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6532905","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013597759","display_name":"Amanda Nash","orcid":"https://orcid.org/0000-0002-7704-4912","observed_orcids":["https://orcid.org/0000-0002-7704-4912"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda M. Nash","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7704-4912","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037092119","display_name":"Samira Aghlara-Fotovat","orcid":"https://orcid.org/0000-0002-1760-3786","observed_orcids":["https://orcid.org/0000-0002-1760-3786"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samira Aghlara-Fotovat","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1760-3786","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059886583","display_name":"Bertha Castillio","orcid":"https://orcid.org/0000-0001-6029-1784","observed_orcids":["https://orcid.org/0000-0001-6029-1784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bertha Castillio","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6029-1784","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052266561","display_name":"Andrea Hern\u00e1ndez","orcid":"https://orcid.org/0000-0001-9301-3780","observed_orcids":["https://orcid.org/0000-0001-9301-3780"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrea Hernandez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9301-3780","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054564988","display_name":"Aarthi Pugazenthi","orcid":"https://orcid.org/0000-0002-6995-3147","observed_orcids":["https://orcid.org/0000-0002-6995-3147"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aarthi Pugazenthi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6995-3147","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074452869","display_name":"Hyun\u2010Sung Lee","orcid":"https://orcid.org/0000-0001-8259-046X","observed_orcids":["https://orcid.org/0000-0001-8259-046X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hyun-Sung Lee","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8259-046X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053919550","display_name":"Hee-Jin Jang","orcid":"https://orcid.org/0000-0001-7031-1398","observed_orcids":["https://orcid.org/0000-0001-7031-1398"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hee-Jin Jang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7031-1398","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054991841","display_name":"Annie Nguyen","orcid":"https://orcid.org/0000-0002-7056-2100","observed_orcids":["https://orcid.org/0000-0002-7056-2100"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annie Nguyen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7056-2100","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072142412","display_name":"Alexander Lu","orcid":"https://orcid.org/0000-0002-1552-7070","observed_orcids":["https://orcid.org/0000-0002-1552-7070"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Lu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1552-7070","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023175421","display_name":"Bryan M. Burt","orcid":"https://orcid.org/0000-0003-0859-4192","observed_orcids":["https://orcid.org/0000-0003-0859-4192","https://orcid.org/0009-0006-2643-4810"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bryan M. Burt","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0859-4192","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078856482","display_name":"Ravi K. Ghanta","orcid":"https://orcid.org/0000-0003-3299-2668","observed_orcids":["https://orcid.org/0000-0003-3299-2668"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ravi K. Ghanta","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3299-2668","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5044696485","display_name":"Omid Veiseh","orcid":"https://orcid.org/0000-0003-1153-8079","observed_orcids":["https://orcid.org/0000-0003-1153-8079"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Omid Veiseh","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1153-8079","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5220000147819519,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5220000147819519,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.41850000619888306,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":0.01269999984651804,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/malignant-mesothelioma","display_name":"malignant mesothelioma","score":0.9380000233650208},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.6859999895095825},{"id":"https://openalex.org/keywords/m2-macrophages","display_name":"M2 macrophages","score":0.7829999923706055},{"id":"https://openalex.org/keywords/m1-like-macrophages","display_name":"M1-like macrophages","score":0.9629999995231628},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.8450000286102295},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.5230000019073486},{"id":"https://openalex.org/keywords/capillary-leak","display_name":"capillary leak syndrome","score":0.7889999747276306}],"concepts":[{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.6909555196762085},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.61006760597229},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4675663113594055},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.4384270906448364},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.43542954325675964},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40358200669288635},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33885055780410767},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33199477195739746}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6532905","doi":"https://doi.org/10.1158/1078-0432.c.6532905","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6532905","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6532905","doi":"https://doi.org/10.1158/1078-0432.c.6532905","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6532905","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4292648223","https://openalex.org/W4308375562","https://openalex.org/W4300688601","https://openalex.org/W4282967523","https://openalex.org/W4294943499","https://openalex.org/W4365511847","https://openalex.org/W2011011577","https://openalex.org/W1875605274","https://openalex.org/W2056229523","https://openalex.org/W4214844808"],"abstract_inverted_index":{"AbstractPurpose:":[0],"IL2":[1,47,69,109,115,153,217],"immunotherapy":[2],"has":[3],"the":[4,52,65,91,96,118,125,203,222,237,249],"potential":[5,212],"to":[6,23,50,221],"elicit":[7],"immune-mediated":[8],"tumor":[9,129,148,233],"lysis":[10],"via":[11],"activation":[12],"of":[13,54,68,76,95,138,143,145,178,205,224,240,252],"effector":[14],"immune":[15,81],"cells,":[16,176],"but":[17],"clinical":[18,214,250],"utility":[19],"is":[20],"limited":[21,122],"due":[22],"pharmacokinetic":[24],"challenges":[25],"as":[26,28],"well":[27],"vascular":[29],"leak":[30],"syndrome":[31],"and":[32,43,90,93,104,141,173,182,190,209,230,235],"other":[33],"life-threatening":[34],"toxicities":[35],"experienced":[36],"by":[37,133,260],"patients.":[38],"We":[39,63],"developed":[40],"a":[41,73,183],"safe":[42],"clinically":[44],"translatable":[45],"localized":[46],"delivery":[48,255],"system":[49],"boost":[51],"potency":[53],"therapy":[55],"while":[56],"minimizing":[57],"systemic":[58,126],"cytokine":[59,70,110,154,206,218],"exposure.":[60],"Experimental":[61],"Design:":[62],"evaluated":[64,99],"therapeutic":[66,238],"efficacy":[67,239],"factories":[71,111,155,219],"in":[72,80,117,171,186,200],"mouse":[74,226],"model":[75],"malignant":[77,227],"mesothelioma.":[78],"Changes":[79],"populations":[82],"were":[83,98,156],"analyzed":[84],"using":[85,100],"time-of-flight":[86],"mass":[87],"cytometry":[88],"(CyTOF),":[89],"safety":[92,204],"translatability":[94],"platform":[97],"complete":[101],"blood":[102,197],"counts":[103],"serum":[105],"chemistry":[106,198],"analysis.":[107],"Results:":[108],"enabled":[112],"150\u00d7":[113],"higher":[114],"concentrations":[116],"local":[119],"compartment":[120],"with":[121,158],"leakage":[123],"into":[124],"circulation.":[127],"AB1":[128],"burden":[130],"was":[131],"reduced":[132],"80%":[134],"after":[135,194],"1":[136,163],"week":[137],"monotherapy":[139],"treatment,":[140],"7":[142,144],"animals":[146],"exhibited":[147],"eradication":[149,223],"without":[150],"recurrence":[151],"when":[152],"combined":[157],"anti\u2013programmed":[159],"cell":[160],"death":[161],"protein":[162],"(aPD1).":[164],"Furthermore,":[165],"CyTOF":[166],"analysis":[167],"showed":[168],"an":[169],"increase":[170,185],"CD69+CD44+":[172],"CD69\u2212CD44+CD62L\u2212":[174],"T":[175],"reduction":[177],"CD86\u2212PD-L1\u2212":[179],"M2-like":[180],"macrophages,":[181],"corresponding":[184],"CD86+PD-L1+":[187],"M1-like":[188],"macrophages":[189],"MHC-II+":[191],"dendritic":[192],"cells":[193],"treatment.":[195],"Finally,":[196],"ranges":[199],"rodents":[201],"demonstrated":[202],"factory":[207],"treatment":[208],"reinforced":[210],"its":[211],"for":[213,248],"use.":[215],"Conclusions:":[216],"led":[220],"aggressive":[225],"mesothelioma":[228],"tumors":[229],"protection":[231],"from":[232],"recurrence,":[234],"increased":[236],"aPD1":[241],"checkpoint":[242],"therapy.":[243],"This":[244],"study":[245],"provides":[246],"support":[247],"evaluation":[251],"this":[253],"IL2-based":[254],"system.":[256],"See":[257],"related":[258],"commentary":[259],"Palanki":[261],"et":[262],"al.,":[263],"p.":[264],"5010":[265]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4361959092","counts_by_year":[],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2023-04-05T00:00:00"}
